You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
智飛生物(300122.SZ)擬3500萬元認購深信生物10.189%股權
格隆匯 12-07 16:04

格隆匯12月7日丨智飛生物(300122.SZ)公佈,為完善新技術平台佈局,提高研發綜合實力,公司擬以自有資金人民幣3500萬元認購深信生物10.189%的股權。

深信生物是一家從事生物科技、醫療科技領域內的技術開發、技術轉讓、技術服務、技術諮詢,藥品的研究與開發的生物科技企業,依託其具有多年研究經驗的研發團隊,在mRNA特別是LNP遞送技術領域搭建了行業領先的技術平台。

公司自成立以來一直注重研發與技術創新,專注研發技術的引進、開發和新技術平台的構建。mRNA技術平台具有其獨特的優越性,也是未來疫苗研發的主要方向之一。此次股權認購,有利於進一步完善佈局,若進展順利,將對強化公司核心競爭力以及公司穩健可持續長期發展產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account